Results 111 to 120 of about 105,769 (255)

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Googling adenomyosis: a systematic review of internet-based information. [PDF]

Rev Assoc Med Bras (1992)
Araújo BP, Silva CSLD, Benetti-Pinto CL, Yela DA.   +3 more
europepmc   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Chronotype-based radiotherapy in localised prostate cancer: protocol for a prospective cohort integrating MCTQ and salivary DLMO. [PDF]

Clin Transl Radiat Oncol
Oliveira-Sousa R, Carriço ÍR, Macedo-Silva C, Barbosa B, Ferreira A, Ribeiro C, Santos J, Castro C, Jerónimo C, Miranda-Gonçalves V.   +9 more
europepmc   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer, Eliza J. McEwin, Zhicheng Wang, Joel Lexchin, Barbara Mintzes   +4 more
wiley   +1 more source

Utilization of Heritage Manifestations in a Reminiscence Programme (App) Directed at Older Adults with and Without Neurocognitive Disorder, Employing AI: A Pilot Study in Portugal and Spain. [PDF]

J Cross Cult Gerontol
Pires NA, Dos Santos PM, Doménech S, Nebot À, Mugica F, Bendahmane AB, Porta X.   +6 more
europepmc   +1 more source

Regulatory harmonization: Evolution, globalization and future directions

British Journal of Clinical Pharmacology, EarlyView.
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm, Elaine Y. L. Blair, Christine Y. Lu   +2 more
wiley   +1 more source

Validity and Reliability of the Portuguese Version of the Nurses' Professionalism Inventory. [PDF]

Nurs Rep
Ribeiro MP, Gasparino RC, Ribeiro OMPL.
europepmc   +1 more source

Prosocial behaviour in primary and secondary school students. Effects of the CYBUPRE intervention

British Educational Research Journal, EarlyView.
Abstract Prosocial behaviour is regarded as a critical factor in reducing aggressive behaviours among peers, both in physical settings and virtual spaces. This variable facilitates the enhancement of social relationships, promoting empathy, deep listening, physical and verbal service, and even solidarity, among other benefits.
Mercedes Chicote‐Beato, Ana Rosa Bodoque‐Osma, Fernando Martins, Sixto González‐Víllora   +3 more
wiley   +1 more source

Brazilian Journal of Anesthesiology: 75 years consolidating achievements. [PDF]

Braz J Anesthesiol
Cangiani LM.
europepmc   +1 more source